F19.1
Other psychoactive substance abuse
Clinical Classification Guidelines
Excludes Type 1
- other psychoactive substance dependence (F19.2-)
- other psychoactive substance use, unspecified (F19.9-)
Medical Intelligence & Overview
Other psychoactive substance abuse, classified under ICD-10 code F19.1, refers to the problematic use of various substances that affect the brain, leading to health, social, and legal issues. This diagnosis encompasses the misuse of substances other than the most commonly abused drugs, highlighting a pattern of harmful consumption that can impact an individual’s well-being and daily functioning. Recognizing and understanding this condition is crucial for addressing the challenges associated with psychoactive substance misuse.
Causes & Symptoms
Clinical Causes: Psychological factors such as stress, depression, or anxiety that may lead individuals to seek relief through substance use. Environmental influences including peer pressure, family history of substance abuse, or societal norms that normalize drug use. Availability of various psychoactive substances in the community or workplace. Co-occurring mental health disorders that increase vulnerability to substance misuse. Genetic predisposition influencing susceptibility to addiction.
Key Symptoms: Craving or a strong desire to use the substance. Inability to control or reduce substance use despite intentions. Neglect of responsibilities at work, school, or home due to substance use. Engaging in risky behaviors such as driving under the influence or unprotected sex. Physical signs like changes in appearance, weight fluctuations, or unexplained health issues. Withdrawal symptoms when not using the substance, such as irritability, tremors, or nausea. Neglect of personal, social, or occupational activities in favor of substance use.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive assessment by a healthcare professional, including a detailed history of substance use, physical examination, and mental health evaluation. Standardized screening tools and questionnaires may be utilized to identify patterns of misuse. It is also important to rule out other medical or psychiatric conditions that might mimic or contribute to the symptoms. The diagnosis of F19.1 indicates problematic use of certain psychoactive substances that do not fall into more specific categories.
Treatment Protocols: Effective management of other psychoactive substance abuse typically involves a multidisciplinary approach, including behavioral therapies, counseling, and support groups. Pharmacological treatments may be used to address withdrawal symptoms or co-occurring mental health issues. Treatment aims to reduce or cease substance use, address underlying psychological causes, and support ongoing recovery. Follow-up care and relapse prevention strategies are essential components of long-term management.
Clinical Advice & FAQs
Billing Guidance
Is F19.1 a billable ICD-10 code?
Yes, F19.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.1?
Clinical documentation must specify the nature of Other psychoactive substance abuse and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
